Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel vs. Aspirin in S. Aureus Bacteremia
NCT06650488Phase 4Recruiting
- Start
- Jan 2026
- Primary completion
- Jan 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in Staphylococcus aureus bacteremia (SAB), Staphylococcus aureus infective endocarditis (SAIE), Staphylococcus aureus sepsis. Started Jan 2026; status: recruiting.
02
Drugs
clopidogrel
03
Conditions
Staphylococcus aureus bacteremia (SAB)Staphylococcus aureus infective endocarditis (SAIE)Staphylococcus aureus sepsis
Beyond the preview
Go deeper on NCT06650488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06650488.